Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.775
+0.095 (5.65%)
Oct 19, 2026, 1:58 PM EDT - Market open
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $212.03 million as of October 19, 2026. It is the 20,754th most valuable company in the world and the 3,566th biggest in the United States. Its market cap has increased by 1.75% in one year.
Market Cap
212.03M
Enterprise Value
196.87M
1-Year Change
1.75%
Global Rank
Country Rank
#3,566 United States
Category
ChartMarket Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $212.03M, a decrease of -59.52%. That is a compound annual growth rate of -16.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 212.03M | 196.12% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 211.36M |
| Protalix BioTherapeutics | 211.10M |
| Sol-Gel Technologies | 210.35M |
| Larimar Therapeutics | 207.20M |
| MacroGenics | 207.03M |
| Alector | 205.45M |
| Zentalis Pharmaceuticals | 201.65M |
| Lyell Immunopharma | 199.72M |